Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of AADAC Genetic Polymorphisms on Hydrolase Activity-Reference-Cited by-同舟云学术

Role of Human Arylacetamide Deacetylase (AADAC) on Hydrolysis of Eslicarbazepine Acetate and Effects of AADAC Genetic Polymorphisms on Hydrolase Activity

Published:2021-01-14 Issue:4 Volume:49 Page:322-329
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Hirosawa Keiya,Fukami Tatsuki,Tashiro Kiyomichi,Sakai Yoshiyuki,Kisui Fumiya,Nakano Masataka,Nakajima Miki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference37 articles.

1. Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment

2. Association of AADAC deletion and Gilles de la Tourette syndrome in a large european cohort;Bertelsen;Biol Psychiatry,2016

3. Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015

4. Bioavailability enhancement of EGCG by structural modification and nano-delivery: a review;Dai;J Funct Foods,2020

5. Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrations

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of miR-222-3p-mediated downregulation of arylacetamide deacetylase on drug hydrolysis and lipid accumulation;Drug Metabolism and Pharmacokinetics;2024-06

2. Role of carboxylesterase and arylacetamide deacetylase in drug metabolism, physiology, and pathology;Biochemical Pharmacology;2024-05

3. Other Phase I metabolic transformations;An Integrated Guide to Human Drug Metabolism;2024

4. In Vitro Evaluation of the Reductase Activities of HumanAKR1C3Allelic Variants;Drug Metabolism and Disposition;2023-06-21

5. Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity Drug;Drug Metabolism and Disposition;2023-05-03